January 3, 2018
Trends in OTC pharma packaging
While physically over-the-counter (OTC) medicine packaging may mirror the prescription drug market, with continued strong demand for plastic primary pharmaceutical…
Pharmaceuticals, Biotechnology and Life Sciences
Category: news
January 3, 2018
Second breakthrough therapy mark for Novartis’s Kisqali
Novartis on Wednesday sadi that Kisqali has gotten US Food and Drug Administration (FDA) Breakthrough Therapy designation for initial endocrine-based…
December 20, 2017
NIH study uncovers clues about why common cancer drug causes hearing loss
Scientists have found a new way to explain the hearing loss caused by cisplatin, a powerful drug used to treat…
December 20, 2017
FDA approves novel gene therapy to treat patients with a rare form of inherited vision loss
The U.S. Food and Drug Administration has approved Spark Therapeutics’s Luxturna (voretigene neparvovec-rzyl), a new gene therapy, to treat children and adult…
December 20, 2017
Portola Pharmaceuticals’s Bevyxxa available to patients in January 2018
U.S. Food and Drug Administration (FDA) has approved the Portola Pharmaceuticals’s Prior Approval Supplement (PAS) for Bevyxxa (betrixaban) ahead of…
December 20, 2017
Boehringer Ingelheim enters into collaboration with Roche to partner for inflammatory bowel diseases
Boehringer Ingelheim today announced a collaborative agreement with Roche, focusing on the discovery and development of orally available novel Locked…
December 20, 2017
BioMarin doses first patient in global GENEr8-1 Phase 3 study
BioMarin Pharmaceutical has dosed the first patient in the global GENEr8-1 Phase 3 study with the 6e13 vg/kg dose for…
December 19, 2017
Shire receives FDA clearance for myPKFiT
The U.S. Food and Drug Administration (FDA) has granted 510(k) marketing clearance to Shire’s myPKFiT for ADVATE, a free web-based…
December 19, 2017
Pfenex cashes $18.5 million in milestones and updates Worldwide License and Option Agreement with Jazz Pharmaceuticals
Pfenex has announced the amendment of the 2016 agreement under which Pfenex granted Jazz Pharmaceuticals worldwide rights to develop and…
December 19, 2017
Hikma nets deal with Celltrion for third biosimilar product in the MENA
Hikma Pharmaceuticals has reached a licensing agreement with South Korea-based Celltrion, Inc. and Celltrion Healthcare, Inc (Celltrion) for the first…